Ann Hanly Net Worth & Insider Trades

Ann Hanly - Chief Technology Officer, Vir Biotechnology, Inc

As of March 31, 2022

What is Ann Hanly's Net Worth?

The current estimated net worth of Vir Biotechnology, Inc's Chief Technology Officer, Ann Hanly, is estimated to be about $659.33K . Ann Hanly owns about 81,485 units of Vir Biotechnology, Inc common stock. In the last year at Vir Biotechnology, Inc, Ann Hanly has sold an estimated value of $68.93K worth.

What is Ann Hanly's Past Insider Trading?

Ann Hanly's largest purchase order was 12 units , worth over $499.85 on December 1, 2021. Ann Hanly's largest sale order was 2,627 units , worth over $68.93K on March 31, 2022. In total, Ann Hanly has made about 4 transactions over a year of their time at Vir Biotechnology, Inc. Ann Hanly usually trades in March, with the busiest year in 2021 and 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ann Hanly's' Mailing Address?

  • Mailing address is C/o Vir Biotechnology, Inc. 499 Illinois Street, Suite 500 San Francisco CA 94158 CA

Vir Biotechnology, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
George Scangos, Ph.D. 2020 $544,583 - - $438,900 $11,400 $994,883
George Scangos, Ph.D. 2019 $514,583 - $3,158,780 $260,044 $11,200 $3,944,607
George Scangos, Ph.D. 2018 $512,019 - - $260,000 $11,000 $783,019
Howard Horn 2020 $444,333 - $960,186 $226,100 $11,400 $1,642,019
Howard Horn 2019 $413,333 - $1,614,687 $174,720 $11,200 $2,213,940
Steven Rice 2020 $441,667 - $1,476,236 $256,956 - $2,174,859
Herbert (“Skip”) Virgin, M.D., Ph.D. 2020 $636,525 - - $374,311 $95,400 $1,106,236
Herbert (“Skip”) Virgin, M.D., Ph.D. 2019 $617,500 - $1,018,963 $248,400 $84,000 $1,968,863
Herbert (“Skip”) Virgin, M.D., Ph.D. 2018 $592,308 $600,000 $627,750 $259,000 $84,000 $2,163,058
Michael Kamarck, Ph.D. 2020 $426,400 - - $266,000 $111,400 $803,800
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1706431/000119312521107570/d318415ddef14a.htm

What are Vir Biotechnology, Inc's Past Insider Trades?

Vir Biotechnology, Inc's most recent insider trade came on December 6, 2022 by Svf Endurance Cayman Ltd, SB Investment Advisers Uk Ltd and Softbank Vision Fund Aiv M Lp who sold 97,293 units worth $2.67M . In the last 19 years, insiders at Vir Biotechnology, Inc have sold an estimated value of $122.25M and bought an estimated value of $148.77M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Herbert Virgin, EVP,  Phillip Pang, Chief Medical Officer,  and Vicki Sato, Director .

Vir Biotechnology, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1